论文部分内容阅读
５－ＨＴ可调节纹状体多巴胺的释放，从而引起运动障碍。赛庚啶（ｃｙｐｒｏｈｅｐｔａｄｉｎｅ）是一种５－ＨＴ拮抗剂，可改善迟发性运动障碍（ＴＤ），而昂丹司琼（ｏｎｄａｎｓｅｔｒｏｎ，枢复宁）为选择性５－ＨＴ３受体拮抗剂，可用于癌症病人的恶心与呕吐，本文就本品
5-HT regulates the release of striatal dopamine, causing dyskinesia. Cyproheptadine is a 5-HT antagonist that improves tardive dyskinesia (TD), while ondansetron is a selective 5-HT3 receptor antagonist that is available In cancer patients with nausea and vomiting, this article on the goods